People on the Move
Navitor Pharmaceuticals
Navitor Pharmaceuticals, a company developing biologics which target cellular nutrient signalling, has announced that industry veteran Eddine Saiah will join the company as VP of Drug Discovery.
Saiah will be responsible for directing Navitor’s research activities around the discovery of selective modulators of mTORC1 to address a range of diseases including metabolic, neurodegenerative, autoimmune and musculoskeletal diseases.
Saiah has worked for over 20 years in drug discovery and has experience in diabetes, obesity, oncology, inflammation, cardiovascular and pain.
Most recently, he led the drug discovery and medicinal chemistry activities for several portfolio companies of Atlas Venture including Raze Therapeutics and Quartet Medicine.
Previously, he held senior R&D roles at Pfizer and Wyeth Research.